Tidl Pain Relief Numbing
NDC Package 79740-009-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Tidl Pain Relief Numbing is uses Temporary relief from minor aches and pains of muscles and joints associated with arthritis, simple backache, strains and sprains. Marketed by The Anthos Group, this product is identified by NDC 79740-009 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
79740-009-01
Package Description
5 BAG in 1 BOX / 1 PATCH in 1 BAG (79740-009-02)
Product Code
79740-009
11-Digit Billing Format
79740000901
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tidl Pain Relief Numbing Tidl
Dosage Form
-
Usage Information
Uses Temporary relief from minor aches and pains of muscles and joints associated with arthritis, simple backache, strains and sprains

Regulatory & Marketing

Labeler Name
The Anthos Group
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-31-2020
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 79740-009-01 identifies a specific commercial package of 5 bag in 1 box / 1 patch in 1 bag (79740-009-02) of Tidl Pain Relief Numbing Tidl, labeled by The Anthos Group. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by The Anthos Group on August 31, 2020. The current certification is valid through December 31, 2025.

How is this The Anthos Group product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 79740000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
79740-009-01
11-Digit CMS (5-4-2)
79740-0009-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.